WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Recursion Pharmaceuticals revenue was $68.23M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2026) ending on Sep 30, 2026 was $18.6M, up 141.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RXRX annual revenue was $74.7M, with 26.9% growth year-over-year.

RXRX past revenue growth

How has RXRX's revenue growth performed historically?

Company
56.18%
Industry
171.94%
Market
25.07%
RXRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RXRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RXRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RXRX revenue history

Current Revenue
$68.2M
Current Earnings
-$475.7M
Current Profit Margin
-697.1%

Be the first to know when RXRX announces revenue.

RXRX Revenue History By Year

RXRX Yearly RevenueRXRX RevenueRXRX ChangeRXRX Revenue Growth
2025-12-31$74.68M$15.84M+26.92%
2024-12-31$58.84M$14.26M+32.00%
2023-12-31$44.58M$4.73M+11.88%
2022-12-31$39.84M$29.67M+291.46%
2021-12-31$10.18M$6.22M+156.89%
2020-12-31$3.96M$1.64M+70.85%
2019-12-31$2.32MN/AN/A

1 of 1

Recursion Pharmaceuticals Revenue FAQ

What was RXRX's revenue last quarter?

On Nov 2, 2026, Recursion Pharmaceuticals (NASDAQ: RXRX) reported Q3 2026 revenue of $18.55 million up 258.49% year over year. In the same quarter last year, Recursion Pharmaceuticals's revenue was $5.18 million.

What was Recursion Pharmaceuticals's revenue in 2025?

Recursion Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $74.68 million, a 26.92% increase year over year.

How much does Recursion Pharmaceuticals make in a day?

Based on Recursion Pharmaceuticals annual revenue for the past five years, RXRX makes an average of $124,995.07 per day.

What was Recursion Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2026, Recursion Pharmaceuticals's revenue has grown 56.18% year over year. This is 115.76 percentage points lower than the US Biotechnology industry revenue growth rate of 171.94%. Recursion Pharmaceuticals's revenue in the past year totaled $68.23 million.

How much does Recursion Pharmaceuticals make in a year?

Recursion Pharmaceuticals's revenue by year for the past five years is:
  • Recursion Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $74.68 million, a 26.92% increase year over year.
  • Recursion Pharmaceuticals's annual revenue for Dec 31, 2024 was $58.84 million, a 32% increase from 2023.
  • Recursion Pharmaceuticals's annual revenue for 2023 was $44.58 million, a 11.88% increase from 2022.
  • Recursion Pharmaceuticals's annual revenue for 2022 was $39.84 million, a 291.46% increase from 2021.
  • Recursion Pharmaceuticals's annual revenue for 2021 was $10.18 million, a 156.89% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.